SYRESpyre Therapeutics, Inc.Mar 7, 2019Q4 2018
Read transcript →Spyre Therapeutics, Inc. (SYRE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$101.22
+6.64%
Mkt Cap $8.50B
SYRESpyre Therapeutics, Inc.Mar 7, 2019SYRESpyre Therapeutics, Inc.Mar 23, 2017Q4 2016
Read transcript →